Trials / Recruiting
RecruitingNCT05372263
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 3 Months – 85 Years
- Healthy volunteers
- Not accepted
Summary
Recruit at least 700 PH patients, follow up every 6 months based on a computerized follow-up system. Primary outcomes are adverse drug events and all-cause death.
Conditions
Timeline
- Start date
- 2021-08-26
- Primary completion
- 2026-08-31
- Completion
- 2026-12-31
- First posted
- 2022-05-12
- Last updated
- 2025-12-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05372263. Inclusion in this directory is not an endorsement.